Colletti, A.; Citi, V.; Martelli, A.; Pellizzato, M.; Riccardi, E.; Cravotto, G.
Real-World Pilot Evaluation of a Novel Bioavailable Berberine Formulation (ToBeRock®) in Subjects with Impaired Fasting Glucose Through Pharmacy-Based Retrospective Study. Sci. Pharm. 2025, 93, 42.
https://doi.org/10.3390/scipharm93030042
AMA Style
Colletti A, Citi V, Martelli A, Pellizzato M, Riccardi E, Cravotto G.
Real-World Pilot Evaluation of a Novel Bioavailable Berberine Formulation (ToBeRock®) in Subjects with Impaired Fasting Glucose Through Pharmacy-Based Retrospective Study. Scientia Pharmaceutica. 2025; 93(3):42.
https://doi.org/10.3390/scipharm93030042
Chicago/Turabian Style
Colletti, Alessandro, Valentina Citi, Alma Martelli, Marzia Pellizzato, Enzo Riccardi, and Giancarlo Cravotto.
2025. "Real-World Pilot Evaluation of a Novel Bioavailable Berberine Formulation (ToBeRock®) in Subjects with Impaired Fasting Glucose Through Pharmacy-Based Retrospective Study" Scientia Pharmaceutica 93, no. 3: 42.
https://doi.org/10.3390/scipharm93030042
APA Style
Colletti, A., Citi, V., Martelli, A., Pellizzato, M., Riccardi, E., & Cravotto, G.
(2025). Real-World Pilot Evaluation of a Novel Bioavailable Berberine Formulation (ToBeRock®) in Subjects with Impaired Fasting Glucose Through Pharmacy-Based Retrospective Study. Scientia Pharmaceutica, 93(3), 42.
https://doi.org/10.3390/scipharm93030042
